MedTrace Logo

NeoRad Breast Cancer Study

NCT04261244 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1826

Last updated 2025-05-07

No results posted yet for this study

Summary

The NEORAD trial tests whether preoperative radiotherapy results in an improved DFS and less radiation induced late effect compared to postoperative radiotherapy in higher risk breast cancer after NACT.

Conditions

Interventions

RADIATION

preoperative radiotherapy

preoperative radiotherapy instead of postoperative radiotherapy in breast cancer after neoadjuvant chemotherapy

RADIATION

postoperative radiotherapy

postoperative radiotherapy in breast cancer after neoadjuvant chemotherapy

Sponsors & Collaborators

  • Bielefeld University

    lead OTHER

Principal Investigators

  • Christiane M Prof., MD Prof. · Bielefeld University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2028-03-31
Completion
2034-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04261244 on ClinicalTrials.gov